Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- New testosterone assays may become gold standard
-
- Waiting for HAPO: Why the results are so anticipated
- Congress delays 10.1% cut to Medicare physician payments
- ENHANCE data: Ezetimibe did not reduce IMT for patients with genetic disorder
- Is pharmacologic intervention needed to prevent type 2 after gestational diabetes?
- Is there reliable evidence that female androgen deficiency syndrome exists?
- Renew enthusiasm for academic endocrinology Edward C. Chao, DO
- Controversial ‘father’ of endocrinology: Brown-Séquard
- Diabetes in pregnancy – you cannot turn back time Ronald Tamler, MD, PhD, MBA
-
- One you may have missed Alexandra Freeman, MD; Victoria Anderson, CDR, USPHS, MSN, CRNP
- Pay for Performance: the role of the diabetes educator Virginia Zamudio Lange, RN, MSN, CDE
- Our goal: to provide rapid, reliable news and insight about the news Alan J. Garber, MD, PhD, MACE
- Pancreatitis and exenatide: What is the risk? Zachary T. Bloomgarden, MD, MACE, FASPC
- FDA alert: Severe musculoskeletal pain a risk with bisphosphonates
- FDA takes action against compounded hormone therapy drugs
- Bloodletting: an early treatment used by barbers, surgeons
- MRI/MRA imaging: diagnosing molar pregnancy Elizabeth N. Pearce, MD, MSc
-
- Pay-for-performance: physicians as pets Richard O. Dolinar, MD
- ADA issues position statement on standards of medical care
- Bloodletting improved insulin secretion and sensitivity in a recent trial
- Consider race, age when evaluating androgen levels in women
- Diabetes remission linked to gastric banding surgery
- Early primary hyperparathyroidism prevalent in premenopausal women
- Evidence to show results of data reporting limited
- Familial factors influenced complications of type 1 diabetes
-
- Hispanic boys face unique issues with obesity prevention
- Hormone abuse increasing among youth and athletes
- Hypoglycemia incidence highest in early pregnancy
- Intensive insulin therapy in patients with sepsis increased risk for serious adverse events
- Nerve fiber loss linked to severe diabetic neuropathy
- Obese patients recovered faster in a rehab facility
- Oral bisphosphonates reduced risk for jaw degradation
- People with type 2 diabetes had more liver fat than people without diabetes
-
- Pioglitazone or ramipril plus intensive insulin therapy improved vascular dysfunction
- Teriparatide had positive outcomes on BMD in postmenopausal women
- Teriparatide increased BMD in high-risk patients
- Testosterone insufficiency linked to increased mortality in older men
- TRIAD: Sex disparities present in cardiovascular disease mortality trends
- Vildagliptin recommended for treating prediabetes
- Vitamin D deficiency associated with increased risk for CVD
- Childhood obesity predicts cardiovascular disease in adults Janet H. Silverstein, MD
-
- Nurse traveled to Africa to treat foot wounds caused by diabetes
- Inform patients about ways to minimize medication errors Rhonda Cooper-DeHoff, PharmD